Stanford researchers have developed a method for estimating the risk for disease on a genome-wide scale while incorporating population and familial haplotype phasing.
Stanford researchers have developed a novel method that enlarges the search space for disease-gene relationships. The main barrier to genome interpretation is the inherent difficulty in prioritizing the millions of genetic variants in known genes.
Stanford inventors have developed a series of methods which can identify genetic variants and medical genotypes through the phasing of genetic data with the use of Mendelian inheritance as quality control.